Cargando…

Drug-Diagnostics Co-Development in Oncology

Detalles Bibliográficos
Autor principal:	Jørgensen, Jan Trøst
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120852/ https://www.ncbi.nlm.nih.gov/pubmed/25136515 http://dx.doi.org/10.3389/fonc.2014.00208

Ejemplares similares

Drug-Diagnostics Co-Development in Oncology
por: Simon, Richard
Publicado: (2013)

Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects
por: Olsen, Dana, et al.
Publicado: (2014)

A Companion Diagnostic With Significant Clinical Impact in Treatment of Breast and Gastric Cancer
por: Jørgensen, Jan Trøst, et al.
Publicado: (2021)

Medical Oncology or Surgical Oncology: Which Branch Should Be Started in Esophageal Cancer Diagnostic Evaluation?
por: Yıldırım, Özgen Ahmet, et al.
Publicado: (2022)

The current landscape of the FDA approved companion diagnostics
por: Jørgensen, Jan Trøst
Publicado: (2021)

Editorial: Reshaping the diagnostic process in oncology: science versus technology
por: Grizzi, Fabio, et al.
Publicado: (2023)

Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
por: Yap, Timothy A., et al.
Publicado: (2022)

Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology
por: Buzdin, Anton, et al.
Publicado: (2021)

From bench to bedside, 2-in-1 design expedites phase 2/3 oncology drug development
por: Chen, Cong, et al.
Publicado: (2023)

Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
por: Jørgensen, Jan Trøst, et al.
Publicado: (2022)

Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States
por: Huang, Huiyao, et al.
Publicado: (2022)

New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
por: Cruz-Burgos, Marian, et al.
Publicado: (2021)

Therapeutic drug monitoring in oncology - What’s out there: A bibliometric evaluation on the topic
por: Stojanova, Jana, et al.
Publicado: (2022)

Computational approaches for drug repurposing in oncology: untapped opportunity for high value innovation
por: Dalwadi, Shraddha M., et al.
Publicado: (2023)

Development of a Comprehensive Radiation Oncology Quality and Safety Program
por: Sternick, Edward S.
Publicado: (2014)

Editorial: Methods in neuro-oncology and neurosurgical oncology
por: Zoli, Matteo, et al.
Publicado: (2023)

The Oncology Safety of Diagnostic Hysteroscopy in Early-Stage Endometrial Cancer: A Systematic Review and Meta-Analysis
por: Du, Yi, et al.
Publicado: (2021)

Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021
por: Sulman, Erik P., et al.
Publicado: (2023)

Editorial: Rising stars in neuro-oncology and neurosurgical oncology 2021
por: Edwards, Lincoln, et al.
Publicado: (2022)

Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology
por: Sulman, Erik P., et al.
Publicado: (2023)

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2021)

Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects
por: Hegde, Manasa Manjunath, et al.
Publicado: (2023)

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014)

Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs
por: Wen, Hai-ni, et al.
Publicado: (2022)

Oncological Safety of Diagnostic Hysteroscopy for Apparent Early-Stage Type II Endometrial Cancer: A Multicenter Retrospective Cohort Study
por: Zhou, Hui, et al.
Publicado: (2022)

Grand Challenges in Oncology
por: Giaccone, Giuseppe
Publicado: (2011)

Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?
por: Peeken, Jan C., et al.
Publicado: (2017)

Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology
por: Nolan, Michael W., et al.
Publicado: (2019)

Exercise as cancer treatment: A clinical oncology framework for exercise oncology research
por: Courneya, Kerry S., et al.
Publicado: (2022)

Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients
por: Reschke, Agnes, et al.
Publicado: (2022)

The Different Roles of MET in the Development and Treatment of Cancer
por: Mollerup, Jens, et al.
Publicado: (2023)

Radiation Oncology: Today and Tomorrow
por: Kinsella, Timothy James
Publicado: (2011)

Editorial: Charged Particles in Oncology
por: Durante, Marco, et al.
Publicado: (2017)

Editorial: Precision Medicine in Oncology
por: Re, Angela, et al.
Publicado: (2018)

The Time for Chronotherapy in Radiation Oncology
por: Bermúdez-Guzmán, Luis, et al.
Publicado: (2021)

Anesthesia and Oncology: Friend or Foe?
por: Buddeberg, Bigna S., et al.
Publicado: (2022)

Editorial: Reviews in genitourinary oncology
por: Arcangeli, Stefano, et al.
Publicado: (2023)

Editorial: Methods in gynecological oncology
por: Perelli, Federica, et al.
Publicado: (2023)

Editorial: Methods in thoracic oncology
por: Stojšić, Jelena, et al.
Publicado: (2023)

Editorial: Reviews in thoracic oncology
por: Kanellakis, Nikolaos I.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_beh0l2nddfv6vv3b8kj0dpk1hn